Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Sai Life Sciences | Sources told CNBC-TV18 that private equity investor TPG Asia is likely preparing to sell up to 14.72% stake, or about 3.07 crore shares, in Sai Life Sciences Ltd via block deals. The proposed sale, valued at nearly ₹2,500 crore, has a floor price fixed at
Sai Life Sciences TPG Asia VII SF is likely to exit the company by selling its entire 14.72% stake (3.07 crore equity shares) via block deals, with the offer size at Rs 2,500 crore and the floor price at Rs 860 per share, reports CNBC-TV18, quoting sources.
#Bulk Deals Tamil Nadu Newsprint and Papers The Life Insurance Corporation of India (LIC) has offloaded 4 lakh shares (equivalent to 0.58% of paid-up equity) at Rs 171 per share. As of June 2025, LIC held a 1.8% stake (12.46 lakh shares) in the company. Capital Infra Trust
Suneeta Reddy Pottipatti, Managing Director and promoter of Apollo Hospitals Enterprise Limited, sold a 1.3% stake in the company through a block deal on August 22, 2025. The transaction involved the sale of approximately 1.9 million equity shares at a price of ₹7,850 per share, totaling around ₹1,489 crore. This sale price represented a roughly 1% discount compared to the previous day's closing price. The move is seen as a calibrated effort by the promoter group to reduce debt. Separately, the Life Insurance Corporation of India (LIC) offloaded 400,000 shares, equivalent to 0.58% of Tamil Nadu Newsprint and Papers' paid-up equity, at ₹171 per share. Additionally, private equity firm TPG Asia VII SF is preparing to exit Sai Life Sciences by selling its entire 14.72% stake, approximately 30.7 million shares, via block deals with an offer size of about ₹2,500 crore and a floor price of ₹860 per share.
